Stryker Corporation
Stryker Corporation (NYSE: SYK) develops and sells medical technologies in MedSurg, Neurotechnology and Orthopaedics to doctors, hospitals and other healthcare facilities worldwide. Its products include surgical equipment and navigation systems, endoscopic and communications systems, patient-handling and emergency… From the company’s description.
In fiscal 2025, Stryker Corporation reported revenue of $25.12B, up 11.2% from fiscal 2024, and net income of $3.25B. Its operating margin was 19.5%, and operations generated $5.04B in cash. Over the twelve months to Jun 30, 2026, revenue was $25.84B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Stryker Corporation does
In the company’s own words
Stryker Corporation (NYSE: SYK) develops and sells medical technologies in MedSurg, Neurotechnology and Orthopaedics to doctors, hospitals and other healthcare facilities worldwide. Its products include surgical equipment and navigation systems, endoscopic and communications systems, patient-handling and emergency medical equipment, intensive-care products, clinical communication and virtual-care technology, devices for stroke and other vascular conditions, cranial surgery products, and implants for joint replacement, trauma and extremity procedures. Its Mako SmartRobotics platform supports robotic-assisted orthopaedic surgery. Stryker reports two segments: MedSurg and Neurotechnology, which generated 62% of 2025 net sales, and Orthopaedics, which generated 38%. The company sells in approximately 61 countries through subsidiaries, branches, dealers and distributors. Net sales were $25.1 billion in 2025, and it had approximately 56,000 employees globally at year-end. Founded in 1941 by orthopaedic surgeon and inventor Homer H. Stryker, the company was incorporated in Michigan in 1946 as the successor to his business. Its website is www.stryker.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- PORTAGE, MI
- Fiscal year end
- December
- CIK
- 310764
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Stryker Corporation — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Stryker Corporation · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Stryker Corporation’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Stryker Corporation’s bonds, as funds hold them
Funds report holding 20 issues of Stryker Corporation’s debt, $1.45B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.17%, maturing 2027 to 2050.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Stryker Corporation and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Stryker Corporation's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Stryker Corporation's last four quarterly filings that the numbers alone won't show?”
